• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.31% Nasdaq Up0.98%

    Valeant Pharmaceuticals International, Inc. (VRX)

    161.51 Up 0.92(0.57%) Jan 29, 4:04PM EST
    |After Hours : 162.70 Up 1.19 (0.74%) Jan 29, 6:18PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):3.0
    Mean Recommendation (last week):3.4

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:52.38
    Median Target:50.00
    High Target:75.00
    Low Target:34.50
    No. of Brokers:4

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Oct 30, 2013FBR CapitalInitiated Outperform
    Jun 10, 2013CRT CapitalUpgradeHoldBuy
    Feb 22, 2013Aegis CapitalInitiated Buy
    Feb 5, 2010Jefferies & CoInitiated Buy
    Jul 9, 2009Leerink SwannDowngradeOutperformMkt Perform
    Jun 9, 2009WachoviaDowngradeMkt PerformUnderperform
    May 14, 2009Ladenburg ThalmannInitiated Neutral
    May 14, 2009SoleilInitiated Sell
    Mar 24, 2009Leerink SwannInitiated Outperform
    Oct 28, 2008Brean MurrayInitiated Sell

    More Upgrades & Downgrades for VRX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy7776

    Data provided by Thomson/First Call

    Currency in USD.